Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cocrystal Pharma announces appointment of new independent registered public accounting firm - Form 8-K


Thursday, 24 Apr 2014 05:27pm EDT 

Cocrystal Pharma Inc:On April 22, dismissed Paritz & Company, P.A. (the former auditor) as independent registered public accounting firm.On April 18, BDO USA, LLP was appointed to serve as new independent registered public accounting firm. 

Company Quote

0.32
0.015 +4.92%
23 Jul 2014